Federal Policy
CBP Delays Customs Rule That Threatened Drug Imports Until January
Customs and Border Protection pushed back, from Oct. 22 to Jan. 20, a new rule requiring detailed coding and tariff paperwork on low-value international parcels, including personal prescription drug shipments from Canadian pharmacies. The rule was intended to help collect tariffs and catch illegal drugs like fentanyl, but advocates warned it would effectively halt imports that millions of Americans rely on for cheaper medications. The delay followed pressure from patient advocacy groups, 71 congressional Democrats, Florida Republicans, and Trump ally Laura Loomer, who argued the change would raise drug costs ahead of the midterms. Advocates say the underlying threat to personal drug importation remains and the next 90 days are critical.
Why it mattersState Medicaid agencies, pharmacy stakeholders, and patients relying on cross-border personal drug importation face continued uncertainty over whether low-cost supply channels will survive past January, with direct implications for drug affordability and state importation programs in Florida and Colorado.